Detailed Narrative
Q3 FY25 Performance and 9M Overview
India Pesticides reported a 13% year-on-year revenue growth in Q3 FY25, achieving a total income of INR175 crores, driven by a 30% increase in sales volumes. Domestic revenue significantly increased to INR97 crores from INR64 crores in Q3 FY24, while export revenue saw a decline to INR75 crores from INR87 crores. For the nine months of FY25, total revenue reached INR633 crores, marking a 12% increase, with EBITDA growing by 6.3% to INR101 crores, resulting in an EBITDA margin of 15.9%.
Margin Compression and Cost Factors
Despite revenue growth, the EBITDA margin for Q3 FY25 stood at 16.7%, impacted by several factors. Pricing adjustments in the international market, increased freight costs due to logistical challenges in the Red Sea region, and higher employee expenses for R&D and workforce strengthening contributed to the margin decline. The company noted that while gross margins remained stable, these operational and strategic investments added to the overall cost base.
Market Dynamics and Pricing Environment
The agrochemical industry continues to navigate a dynamic environment, with export demand constrained by persistent price volatility and market oversupply, particularly from China. Management indicated that prices are subdued, with a 15% YoY decline in Q3 FY25, following a 20% decline in the previous quarter. Current prices are significantly below 2019 pre-COVID levels, with some products experiencing declines of over 50%, prompting the company to focus on efficiency to meet these price points.
Strategic Capacity Expansion and New Product Focus
India Pesticides is progressing with its capacity expansion plans, especially at its Hamirpur facility, which is expected to start contributing revenue from FY26. An annual capex of around INR50 crores is planned for Hamirpur, with 2 new blocks scheduled for construction in FY26 as part of a larger plan for 10-12 blocks. These new facilities will focus on adding new products and intermediates, including one insecticide and one herbicide, to diversify the product portfolio and avoid duplicating existing Sandila offerings. Registration work for these new molecules is actively underway.
Working Capital and Inventory Management
The company's cash conversion cycle has extended, with inventory days increasing to approximately 170 days. This rise is attributed to a strategic decision to build inventory for a high-selling herbicide product in preparation for the upcoming Kharif season. Management anticipates an improvement in the working capital cycle, projecting a reduction of 20-25 days from the March quarter onwards as the accumulated inventory is sold in Q4.
Outlook and Future Growth Targets
India Pesticides aims to maintain its EBITDA margins within the range of 16% to 18% in the coming quarters⏳ and targets a revenue growth of 15% to 20% for the next year. This growth is expected to be driven by a combination of approximately 10% from existing operations and at least 10% incremental growth from the ongoing capex projects. The company also expects to improve its current capacity utilization from 60% to 85% if international market demand shows signs of recovery.